Manjool Shah, MD

NEW YORK — In this presentation from OSN New York, Manjool M. Shah, MD, discusses why stand-alone canal-based MIGS is an alternative to topical medications for glaucoma treatment.

NEW YORK — In a presentation at OSN New York, Manjool Shah, MD, discusses how surgeons can identify patients with glaucoma who may benefit from transscleral gel stents and provides tips to prepare for an effective surgery.

CHICAGO – At the American Academy of Ophthalmology meeting, Manjool Shah, MD, discusses improvements in surgical technology in the glaucoma space, particularly focusing on the Allergan Xen gel stent for patients with refractory disease.

WASHINGTON ― At the American Society of Cataract and Refractive Surgery meeting here, Manjool Shah, MD, discusses his experience as well as reports from other surgeons on their use of the Xen implant (Allergan) at 1 year for the treatment of refractory glaucoma.